<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001741533</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001730430</issuerCik>
      <issuerName>Kiniksa Pharmaceuticals, Ltd.</issuerName>
      <secFileNumber>001-38492</secFileNumber>
      <issuerAddress>
        <com:street1>CLARENDON HOUSE</com:street1>
        <com:street2>2 CHURCH STREET</com:street2>
        <com:city>HAMILTON</com:city>
        <com:stateOrCountry>D0</com:stateOrCountry>
        <com:zipCode>HM11</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>7814399100</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Paolini John F.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab &amp; Co., Inc.</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>29000</noOfUnitsSold>
      <aggregateMarketValue>555201.00</aggregateMarketValue>
      <noOfUnitsOutstanding>34970866</noOfUnitsOutstanding>
      <approxSaleDate>07/25/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>07/25/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Employee Stock Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Kiniksa Pharmaceuticals, Ltd.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>29000</amountOfSecuritiesAcquired>
      <paymentDate>07/25/2023</paymentDate>
      <natureOfPayment>Broker Payment for Cashless Exercise</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>07/25/2023</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>08/16/2022</planAdoptionDate>
      </planAdoptionDates>
      <signature>John F. Paolini</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2932}]
144
0001741533
XXXXXXXX
LIVE
0001730430
Kiniksa Pharmaceuticals, Ltd.
001-38492
CLARENDON HOUSE
2 CHURCH STREET
HAMILTON
D0
HM11
7814399100
Paolini John F.
Officer
Common
Charles Schwab & Co., Inc.
3000 Schwab Way
Westlake
TX
76262
29000
555201.00
34970866
07/25/2023
NASDAQ
Common
07/25/2023
Employee Stock Option Exercise
Kiniksa Pharmaceuticals, Ltd.
N
29000
07/25/2023
Broker Payment for Cashless Exercise
Y
07/25/2023
08/16/2022
John F. Paolini